Show simple item record

dc.contributor.authorPatouillard, Een_US
dc.contributor.authorGriffin, Jen_US
dc.contributor.authorBhatt, Sen_US
dc.contributor.authorGhani, Aen_US
dc.contributor.authorCibulskis, Ren_US
dc.date.accessioned2017-06-22T14:15:03Z
dc.date.available2017-01-04en_US
dc.date.issued2017en_US
dc.date.submitted2017-06-20T09:52:24.927Z
dc.identifier.issn2059-7908en_US
dc.identifier.other2
dc.identifier.other2
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/24518
dc.description.abstractBackground: Access to malaria control interventions falls short of universal health coverage. The Global Technical Strategy for malaria targets at least 90% reduction in case incidence and mortality rates, and elimination in 35 countries by 2030. The potential to reach these targets will be determined in part by investments in malaria. This study estimates the financing required for malaria control and elimination over the 2016-2030 period. Methods: A mathematical transmission model was used to explore the impact of increasing intervention coverage on burden and costs. The cost analysis took a public provider perspective covering all 97 malaria endemic countries and territories in 2015. All control interventions currently recommended by the WHO were considered. Cost data were sourced from procurement databases, the peer-reviewed literature, national malaria strategic plans, the WHO-CHOICE project and key informant interviews. Results: Annual investments of $6.4 billion (95% uncertainty interval (UI $4.5-$9.0 billion)) by 2020, $7.7 billion (95% UI $5.4-$10.9 billion) by 2025 and $8.7 billion (95% UI $6.0-$12.3 billion) by 2030 will be required to reach the targets set in the Global Technical Strategy. These are equivalent to annual investment per person at risk of malaria of US$3.90 by 2020, US$4.30 by 2025 and US$4.40 by 2030, compared with US$2.30 if interventions were sustained at current coverage levels. The 20 countries with the highest burden in 2015 will require 88% of the total investment. Conclusions: Given the challenges in increasing domestic and international funding, the efficient use of currently available resources should be a priority.en_US
dc.format.extente000176 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofBMJ Glob Healthen_US
dc.rightsCC-BY
dc.titleGlobal investment targets for malaria control and elimination between 2016 and 2030.en_US
dc.typeArticle
dc.rights.holder© 2017, British Medical Journal
dc.identifier.doi10.1136/bmjgh-2016-000176en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29242750en_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume2en_US
dcterms.dateAccepted2017-01-04en_US
qmul.funderSynthesising data from multiple spatial scales and levels of detail to improve malaria transmission model predictions::Medical Research Council (MRC)en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record